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Abstract 
Aims: 
The aim of this study was to identify the biomechanical, neurological and clinical parameters along with other demographics and life style risk factors that 
could explain the presence of foot ulcer in patients with diabetes in Africa.  
Methods: 
A total of 1270 (M/F:696/574) patients; 77(M/F:53/24) with ulcerated vs 1193 (M/F: 643/550) with non-ulcerated feet; participated in this study. A set of 28 
parameters were collected and compared between the participants with and without active foot ulcers. Multivariate logistic regression was utilised to develop 
an explanatory model for foot ulceration.   
Results: 
Foot swelling (χ2(1,n=1270)=265.9,P=0.000,Phi=0.464) and impaired sensation to monofilament (χ2(2,n=1270)=114.2,P=0.000,Cramer’sV=0.300) showed 
strong association with presence of ulceration. A lower Temperature sensitivity to cold stimuli and limited ankle joint mobility were observed to be significant 
(P<0.05) contributors to ulceration. The logistic regression model can justify the presence of foot ulceration with 95.3% diagnostic accuracy, 99.1 % specificity 
and 37.3% sensitivity.  
Conclusion: 
Participants with ulcerated foot show distinct characteristics in few foot related parameters. Swollen foot, limited ankle mobility, and peripheral sensory 
neuropathy were significant characteristics of patients with diabetic foot ulcer. One out of three patients with ulcerated foot showed common characteristics 
that could be justified by the model. 
Key words,  
Diabetic Foot, Diabetic Neuropathy, Biomechanics, Vascular disease, Diagnosis, plantar soft tissue 
Highlights:  
• 28 parameters were used to explain foot ulcer in 77 of 1270 diabetic patients. 
• Patients with swollen foot were more than 16 times more likely to have DFU.  
• Impaired sensation was significantly associated with presence of DFU 
• Patients with normal ankle mobility were less than half likely to have DFU.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Introduction:  
The life time incidence rate of Diabetic Foot Ulcers was estimated to be between 15 to 25 % 1 and has been recently reported to be between 19 to 34% for 
persons with diabetes 2. The rate of ulcer recurrence is approximated to be 65% in 5 years 2, with more than 50% of diabetic ulcers becoming infected 3. 
Approximately 20% of moderate or severe diabetic foot infections lead to some level of amputation 4 5. Diabetic Foot Ulcer (DFU) is the main cause of lower 
limb amputation in patients with diabetes worldwide1. The presence of diabetic foot ulcers in patient increase the risk of death at 5 years by 2.5 times 6. In 
order to decrease the socioeconomic cost associated with diabetic foot ulcers, a specific management protocol needs to be developed for patients with 
ulcerated foot. For developing such protocols, a thorough knowledge of the clinical characteristics of individuals with diabetic foot ulcer is necessary. 
There has been an abundance of studies on the predictive factors for diabetic foot ulceration 7. A  recent systematic review of literature and meta-analysis 
reported that insensitivity to a 10-g monofilament or one absent pedal pulse as established prognostic factors that identify patients with moderate or 
intermediate risk of foot ulceration8. While history of DFUs or lower-extremity amputations were reported to be sufficient to identify those at high risk of 
developing DFU 8, the studies of patients with active DFU in large cohort ( >200 participants) have been much less frequent 9 10 11 12 13. 
Previous study of patients with active DFU in Australian population have identified that the duration of diabetes, neuropathy and vascular insufficiencies are 
associated with DFU 9;  while in a study  on Asian population age and cigarette smoking were identified as characteristics of patients with DFU 10. Another 
study in North Europe found that age, male gender and macrovascular complications were associated factors for participants with a previous or current DFU. 
People with DFU were reported to be significantly taller than those who never had DFU 11.  In a  study conducted on South American population male gender, 
smoking, neuroischmeic foot and absence of vibration perception were found to be associated with participants with previously healed or current DFU 12. In 
another study on North American population loss of protective sensation, history of amputation, elevated plantar pressure, foot deformities, poor diabetes 
control, duration of diabetes and male sex were found to be associated with participants with current or recently healed DFU 13.  Despite these, there is a 
scarcity of studies in which characteristics of patients with current DFU is considered in a large cohort in Africa.  
While poor glycaemic control was commonly reported as a risk factors for diabetic foot ulceration 14, in study involving smaller cohort of patients alcohol 
consumption was found to be significantly higher in patients with active DFU compared to those with no DFU 15.  
Impaired thermal sensation, associated with small fibre neuropathy has also been associated with presence of neuropathic DFU in small patient population 
16. Despite this, the differences in thermal sensation between ulcerated and non-ulcerated and the association between thermal sensitivity and DFU has not 
been previously investigated in a large cohort of patients. In addition, although recent study on smaller groups pf patients have shown that the plantar 
pressure is significantly higher in patients with DFU, compared to their non-ulcerated counterparts 17, with the exception of few studies i.e. 13 this has not 
been confirmed in other large cohort of patients. 
 
The aim of this study was to identify the biomechanical, neurological and clinical parameters along with other demographics and life style risk factors that 
could explain the presence of DFU in patients with diabetes from African population. 
The first objective of this study is to identify the differences in biomechanical, neurological, clinical, demographics and life style between patients with DFU 
against other patients without DFU. The second objective of this study was to propose an explanatory model that can justify the presence of DFU in this group 
of patients based on their common characteristics. 
 
2. Material and Method   
2.1.  Participants:  
Patients who attended the diabetic foot clinic in Tanzania between Jan 2011 and Dec 2015 were recruited to participate in this study. Ethical approval was 
sought and granted by the local ethics committee and informed consent was obtained from all participants. DFU was defined as a full-thickness wound 
involving the foot or the ankle, distal to and including the malleoli.  The sample size was calculated as 1128 participants based on the prevalence of foot 
ulceration rate of 10%, in the studied group and DFU prevalence OF 7 % in diabetes population in Africa 18 with Alpha level of 5% and power of 95%. Assuming 
a missing data in 1 out 8 participants, an additional 142 participants were needed to be recruited to the study to ensure that the calculated sample size is 
used in every statistical analysis.   
2.2. Data Collection  
A combination of categorical and continuous parameters (as follows) were collected from the patients during a single visit.   
2.2.1. Categorical parameters  
The general categorical parameters were: Smoking (Current smoker, Never smoked, Previous smoker), Alcohol habits (Currently drinks, Never drunk, in the 
past), Previous amputation, and History of Ulceration according to protocols set by IWGDF 19.   
The foot-specific categorical parameters included: Neuropathy (using 10-g monofilament loss of sensation 20 was assessed on both feet at 10 sites including 
Hallux, 3rd Toe, 5th Toe, 1st Met head, 3rd Met head, 5th Met head, lateral midfoot, medial midfoot, centre of the hindfoot, and dorsum of the foot  21. For 
sensitivity to monofilament each patient was categorised into 3 levels as Normal (sensation present in >8 sited), Decreased (sensation present in 4-7 sites) 
and Absent (sensation is felt in < 3 sites).   
Foot deformity was assessed as structural abnormalities in the foot such as Claw/Hammer Toe and Hallux Valgus or prominent metatarsal heads, status after 
Charcot foot, amputations and other foot surgery were considered as having foot deformity 22.  
Skin status was considered as: Dry when Epidermis that lacks moisture or sebum; Fissures:  characterized by a pattern of fine lines, scaling, and fissures; and 
Normal: well-balanced skin eudermic that is neither too oily nor too dry 23 24. Mycosis was considered as fungal infection in between the toes and macerated 
skin 23.     
Nail ingrowth was considered as in-growing toe nail (also known as onychocryptosis) and it was considered as present when the nail grows so that it cuts into 
one or both sides of the paronychium or nail bed 23. Swelling was considered as present when swelling of foot sufficiently pronounced to leave a clear imprint 
of the pressure by a finger23. Presence of callus was also considered to be present based on the protocol proposed in IWGFD guidelines23. 
Specific categorical parameters for each participant were defined as if these occurred on either or both feet for each participant.   
2.2.2. Continuous parameters:  
The general continuous parameters included: Age, Body mass, Height, Shoe size (UK), Duration of Diabetes, Body Mass Index. The foot-specific continuous 
parameters were: Ankle Brachial Pressure Index (ABPI), Vibration Perception Threshold, Temperature Sensation and Tolerance Thresholds and plantar 
pressure.  
Vibration Perception Threshold was measured using a clinically accepted device (Neuropathy Analyser – Vibrotherm – Dx (Diabetik Foot Care India Pvt Ltd, 
Chennai, India) at the wrist, knee, ankle and big toe according to the previous protocol 25. This device was also used to measure the Temperature Sensation 
and Temperature Tolerance Thresholds to cold/warm at: Hallux, 3rd Toe, 5th Toe, underneath the arch and Heel according to the previous protocol 26.  
A plantar pressure platform (EMED, Novel, Munich, Germany) was utilised to measure average plantar pressure during the stance phase of walking were 
measured at 16 sites (Hallux,  2nd Toe, 3rd Toe, 4th Toe, 5th Toe, 1st Met head, 2nd Met head, 3rd Met head, 4th Met head, 5th Met head, lateral midfoot, 
central midfoot, medial midfoot, lateral hindfoot, medical hindfoot, centre of the hindfoot), based on previous protocol 27 where the toes, heel and midfoot 
regions were further divided into more specific regions to allow further in-depth analyses of the plantar pressure . The participants were asked to walk over 
the platform using a two-step protocol 28 after completing  a number of familiarisation trials. The mean of average pressures from 3 stance phases from each 
foot were calculated based on which the overall and regional pressures were reported 29.  All specific continuous parameters were averaged between the left 
and right feet. 
 
2.3. Data analyses  
All statistical tests were performed using IBM® SPSS®v.25.  
2.3.1. Test of differences 
Chi-square test for independence with Yates Continuity Correction was utilized to identify significant (p<0.05) association between categorical parameters 
and the prevalence of DFU.  
Furthermore, given the non-normal distribution of the data which was established through the test of normality (Kolmogorov-Smirnov, p< 0.05), Mann-
Whitney U-Test was utilized to assess significant (p<0.05) differences in continuous parameters between the patients with and without ulceration. 
 
2.3.2. Explanatory model for foot ulceration 
Multivariate logistic regression was utilised to develop the explanatory model for foot ulceration based on the risk factors. Logistic regression was used to 
justify the presence or absence of ulceration based on values of a set of predictor variables (covariates). 
To identify the effect of each set of parameters on the explanatory accuracy of the model, the covariates were entered through 9 blocks of covariates as 
shown in (Table 1).   
These blocks were decided based a hierarchical fashion in which clinically plausible set of similar parameters were included in each consecutive block of 
parameters that were sorted based on increase in the complexity level. Furthermore, for set of parameters across different blocks, diagnostic test of 
multicollinearity (with tolerance value of 0.1 or R2 >0.9) was performed and ensured no independent parameters (covariate) existed across blocks.  
In each block of parameters, an automated backward stepwise selection algorithm (retaining variables with p<0.05 Removal testing is based on the probability 
of the Wald statistic) was used to arrive at the multiple regression model. The collinearity between independent parameters in the same block was taken care 
of by the automated backward stepwise selection algorithm. 
 
Table 1: Blocks representing each set of covariates that were added to reach the final explanatory model. 
 
Logistic regression coefficients were also used to estimate odds ratios for each of the independent variables in the model along with the significance of the 
parameters in the model. Chi-square and significance level based on Hosmer-Lemeshow goodness of fit was used to indicate how worthwhile the model was 
in explaining the presence of ulceration. Furthermore Cox & Snell and Nagelkerke R Square values provided an indication of a pseudo R square value that 
indicates the upper and lower range of variability in ulceration status that can be explained by the model.  
 
The sensitivity (as the percentage of participants with DFU incidence that are identified as having DFU) and specificity (as the percentage on of participants 
with no ulceration incidence that are identified as not having DFU) along with the overall explanatory accuracy (as the percentage of the entire cases that are 
explained correctly) of the method were reported when the consecutive blocks (1 to 9) were added. Furthermore, using the area under the receiver operating 
characteristic (ROC) curve with 95% confidence Ievels were calculated and referred to as the diagnosis strength of the model. 
 
3. Results:  
A total of 1270 (M/F: 696/574) participants as 77 (M/F: 53/24) with ulcerated vs 1193 (M/F: 643/550) with non-ulcerated feet were recruited to the study. 
Table 2, and 3 represent the results related to the test of differences along with the bivariate and multivariate logistic regression for the categorical and 
continuous parameters respectively.  While there was no missing data for the categorical and for the majority of continuous parameters, the TST and TTT 
data were missing for 16-19 participants, and the VPT at knee and Blood Glucose level data were missing for 1 and 3 participants respectively.  The missing 
data was accounted for in all statistical analyses, as indicated in Table 2 and Table 3.  
 
Table 2:  shows the categorical parameters for all participants and for each group of with and with no ulceration. a- P values based on Chi-square test of 
independence (with Yates continuity correction) P <0.5 indicates significant association between ulcerated and non-ulcerated group on the parameter. b- 
Effect size as the Phi coefficient, with small =0.01, Medium = 0.30, Large = 0.50;  c- Effect size as Cramer’s V coefficient (three categories), where small = 0.07, 
Medium = 0.21, Large = 0.35; d – Effect size as Cramer’s V coefficient (four categories), where small = 0.06, Medium = 0.17, Large = 0.29 
 
Table 3: shows the continuous parameters for all participants and for the groups with and with no ulceration. a- Mann-Whitney; r = z / (N1 + N2 )0.5 where 
0.1 small effect, 0.3 medium effect, 0.5 large effect ; Note that  the selection of parameters in the logistic regression model was based on the univariate 
analyses in which parameters with P<0.2 were selected. The P values for these selected parameters are underlined in the table. 
 
3.1. Differences in Categorical parameters 
In comparing the general categorical parameters between the two groups, it was found that male gender, was significantly (P=0.010) associated (with 
presence of ulceration with a small effect size. Significant associations for foot swelling (P= 0.000) and impaired sensation to monofilament (P= 0.000) were 
observed with presence of ulceration (both with large effect size). Also, amputation, foot deformity (P=0.000), Ankle joint limited mobility (P= 0.000) and MTP 
joint limited mobility (P= 0.000) were all significantly associated with ulcerated group (medium effect size). It should also be mentioned that previous 
ulceration (P= 0.046), nail ingrowth (P= 0.008) and skin dryness level (P= 0.002) were all associated significantly with ulcerated group (small effect size).  
3.2. Differences in Continuous parameters 
Whilst comparing general continuous parameters between the two groups, the results of this study indicate that the ulcerated group were significantly (P= 
0.020) taller (small effect size) and had significantly (P= 0.000) longer duration of diabetes (medium effect size).  
Furthermore, in comparison of foot specific continuous parameters between the two groups, the ulcerated group showed a significantly (P= 0.000) higher 
vibration perception threshold (Medium effect size). 
While the plantar pressure were significantly lower at Hallux (P= 0.007); 2nd toe (P= 0.006); 3rd toe (P= 0.000); 4th Toes (P= 0.002); and 5th Toe (P= 0.000) in 
ulcerated patients the plantar pressure at the 1st (P= 0.004)  and 5th MTH (P= 0.042) showed to be significantly higher in ulcerated patients compared to non-
ulcerated patients (all with small effect size). 
The average, total, and all the site-specific TTT and TST to cold probe was significantly (P= 0.000)  lower for the ulcerated group, while the corresponding 
values for TTT and TST to hot probe at all tested sites were significantly (P= 0.000) higher in ulcerated group (all with Medium effect size).  
The VPT at wrist, knee, ankle and Hallux was significantly (P= 0.000) higher in ulcerated group (all with medium effect size), while Blood Glucose level showed 
to be significantly (P= 0.002) lower in ulcerated patients (small effect size).  
3.3. Explanatory model for DFU 
Hosmer-Lemeshow goodness of fit indicated that the model was worthwhile indicated by the goodness of fit test results (χ2=4.882, P=0.770) that indicated 
that the hypothesis of a good fit is not rejected (P>0.05).  
The result of multiple regression analyses with backward stepwise selection algorithm (retaining variables with p<0.05) indicated that only 15 (6 categorical 
and 9 continuous) parameters stayed in the final model. From categorical parameters, only the presence of foot swelling (OR= 16.456; 95%CI=8.199-33.028; 
P= 0.000) and normal ankle mobility (OR=0.438; 95%CI=0.231-0.834; P= 0.012) contributed significantly to justification of presence of DFU (Table 2 and Figure 
1).  
From continuous parameters only four parameters including lower blood sugar level (OR= 0.938; 95%CI=0.885-0.995; P= 0.032), lower average TST to cold 
(OR=0.630; 95%CI=0.445-0.891; P=0.009), higher Average TTT to cold (OR=1.399; 95%CI=1.096-1.786; P=0.007), and lower plantar pressure at the fifth toe 
(OR= 0.977; 95%CI=0.862-0.992; P= 0.003) were shown to be significant identifiers of ulcerated patients.  
 
Figure 1: The Sensitivity ( percentage of the group with ulceration occurrence that is correctly identified by the model)  , Specificity ( percentage of the group 
with No ulceration occurrence that is correctly identified by the model), Identification Accuracy ( percentage of the overall group that is correctly identified by 
the model), along with the Diagnosis Strength ( the areas below the Receiver Operation Curve) of the model when the covariates are added in sequential order 
from left to right. Block 1: The model includes covariate A, B & C; Block 2: The model includes covariates: A, B, C, D, E & F; Block 3: The model includes covariates: 
A, B, C, D, E, F & G; Block 4: The model includes covariates: A, B, C, D, E, F, G & H;  Block 5: The model includes covariates: A, B, C, D, E, F, G & H;  Block 6: The 
model includes covariates: A, B, C, D, E, F, G, H, I, J & K; Block 7: The model includes covariates: A, B, C, D, E, F, G, H, I, J, K, L, and M;  Block 7: The model includes 
covariates: A, B, C, D, E, F, G, H, I, J & K; Block 8: The model includes covariates: A, B, C, D, E, F, G, H, I, J, K, L, M and N; Block 9: The model includes covariates: 
A, B, C, D, E, F, G, H, I, J, K, L, M, N and O.                                                                                                  
Where A: Sex (Female:0; Male:1); B: Duration of Diabetes (in days); C: Blood Glucose level (mmol/L);  D: Amputation (0:without, 1:with); E: Foot deformity (0 
without, 1 with); F: Foot swelling (0:without, 1:with); G: Ankle Mobility ( 0:without, 1:with); H: Sensitivity to monofilament ( 0: Absent, Decreased: 1, Normal: 
2); I: Sum of Temperature Sensitivity Threshold to cold probe(°c);  J: : Average Temperature Sensitivity Threshold to cold probe(°c);  K: Average Temperature 
Tolerance Threshold to cold probe(°c);  L: Temperature Tolerance Threshold to hot probe underneath the arch(°c);  M: Sum of Temperature Tolerance Threshold 
to hot probe (°c); N: Plantar pressure at the centre of the Heel ( kPa); O: Plantar pressure at the Fifth Toe ( kPa).   
Figure 1 shows the effect of each set of parameters on the explanatory accuracy of the model, where the covariates were entered through 9 blocks. 
As indicated in figure 1, while the sensitivity shows a significant increase from Block 1 (0%) to Block 9 (37.3%), the specificity of the model dropped only 
marginally by 0.8% from Block 1 (@ 99.9 %) to Block 9 (99.1%). This has led to the identification accuracy of the model to improve only marginally by 1.5% 
(from 93.8% to 95.3 %). It was also observed that the diagnosis strength of the model was also increased from 70.5% in Block 1 to 73.7% in Block 9.  
The model as a whole could justify between 17.4 % (Cox and Snell R Square) and 47.1 % (Nagelkerke R Square) of the variation in ulceration status. 
 
4. Discussion:   
4.1. Difference in Categorical parameters 
When, comparing the general categorical parameters between the two groups, it was found that male gender, was associated with presence of DFU with a 
small effect size. This has been in line with the previous studies in which significantly higher proportion of patients with DFU reported to be male in western 
population in the North America  13, North Europe 11. However these findings are contrary to the study in Australian population where no significant difference 
in the proportion of male sex in the ulcerated vs non-ulcerated  population was reported 9.  
In this study previous amputation was found to be significantly higher in the ulcerated group which is in line with the results of previous studies on North 
European 11 population.  
From the specific categorical parameter, impaired sensation to monofilament show significant association with presence of ulceration with a large effect size 
(Cramer’s V coefficient = 0.3), indicates the relationship between sensory neuropathy and DFU and is in line with previous studies on Australian 9 population.   
The results of the current study in which a significantly higher number of participants with swollen feet that was observed in the ulcerated (vs non ulcerated) 
group with a large effect size (Phi coefficient = 0.464) was never reported in previous studies where the group of ulcerated and non-ulcerated participants 
were compared. While the difference cannot indicate a causal relationship between ulcer and presence of foot swelling, the finding can have implications in 
designing footwear interventions for this group of patients.  
Foot deformity has been associated with a medium effect size in the current study. Although there is no study with comparable population size against which 
the results of this study can be compared, our findings are in line with the results by Fernando and co-workers 17 who reported significantly higher proportion 
of patients with Hammer toe deformity in the ulcerated group compared to the group with diabetic neuropathy.  
The inconclusive results of this study re the contribution of Alcohol ingestion to justifying the risk of diabetic foot ulceration are in line with previous findings 
on Australian 9, North American 13 and Asian 10 population. Furthermore the inconclusive results of the current study  regarding smoking as a contributing 
factor to justify the presence of DFU are in line with the previous study in North European 11, North American 13 and Australian 9 population, while it 
contradicted the results on South American 12 and Asian 10  populations where smoking was reported as a  contributing factor to justify diabetic foot ulceration.  
 
Ankle and MTP joint limited mobilities were all associated with ulcerated group (medium effect size), that is in contrary to the findings by Fernando and co-
workers 17 in which no significant difference was found between either of the parameters and ulceration.  
 
4.2. Difference in Continuous parameters 
The results of this study are in line with the previous literature in which patients with ulcers have shown to have higher duration of diabetes compared to 
their non-ulcerated counterparts in studies of South American 12, North European 11 and Australian 9 population. 
While the results of the current study indicated that the ulcerated group were significantly taller that is in line with findings on North European population 11, 
the results of the current study  are contrary to the findings reported for Australian population 9, who found no significant difference in height of ulcerated 
and non-ulcerated group.  
The  results of the current study on the plantar pressure at the toes also contradict the results by Fernando and co-workers  17 who reported a significantly 
higher pressure at these sites in patients with DFU. Although the difference may be due to the fact that the previous study  17 measured pressure at the entire 
area under the lesser toes, the current study measured the pressure under toes separately.   
Furthermore, the results of the current study that indicate that the plantar pressure at the 1st and 5th MTH are significantly higher in ulcerated patients when 
compared to non-ulcerated patients (all with small effect size). However no such significant differences were reported by Fernando and co-workers  17.  
As opposed to the previous study 17, the current  study found no significant difference in the plantar pressure at the midfoot between the ulcerated and non-
ulcerated group. This may also be related to the fact that in the current study 3 different zones of midfoot were considered separately.  
The average, total, and all the site-specific TTT and TST to cold probe was significantly lower for the ulcerated group, while the corresponding values for TTT 
and TST to hot probe at all tested sites were significantly higher in ulcerated group (all with Medium effect size). This distinct feature of ulcerated patients 
indicate presence of small fibre neuropathy that is in line with the previous findings 16.  
The values of average VPT at foot and VPT at wrist, knee, ankle and Hallux was significantly higher in ulcerated group (medium effect size) are in line with our 
earlier the findings that significantly higher number of participants with ulcerated foot showed neuropathy.  
While the finding of this study that indicated that the Blood Glucose level showed to be significantly lower in ulcerated patients (small effect size) seem to be 
contradictory to previous studies in North Europe 11 , Australian 9 and South America 12 where  Glycated Haemoglobin ( HbA1c) was reported to be significantly 
higher in ulcerated vs nonulcerated group.  However the reduced blood sugar level in ulcerated group in the current study may be the effect of trauma rather 
than on blood sugar level rather than being an existing condition before the ulceration.   
 
4.3. The explanatory model 
The model was adequately specific in identifying the factors that protect the patients against ulceration. However, the ability of model in justifying the 
characteristics of patients with ulcerated foot is currently relatively limited. With just over 1 out of three patients with ulcerated foot showing common 
characteristics based on the parameters that were investigated in this study. However comparison between this model that is proposed in the current study 
against what was proposed for other patient populations in North America 13,  South America 12, North Europe 11 , Asia 10 and Australia 9 is not possible as 
these have not reported the accuracy of the model in terms of sensitivity, specificity and diagnosis power.  
Only six parameters (foot swelling, ankle joint mobility, blood Glucose Level, Average TTT and TST to cold probe and plantar pressure at the fifth toe) were 
found to be significantly (p<0.05) contributed to the model in the current study.  
In essence the findings indicate that a patient with swollen foot is more than 16 times (OR= 16.456) more likely to have DFU and that a patients with normal 
ankle mobility is less than half likely (OR=0.438) to have DFU. 
It is interesting to observe that none of the parameters that were found in the explanatory model of the current study are among parameters that were 
reported to be significant risk factor for diabetic foot ulceration in previous studies on different patient populations in North America13, South America12,  
North Europe11 , Asia10 and Australia 9.  
It is also worth mentioning that with the exception of Blood Glucose Level all other parameters that significantly contributed to justify the presence of DFU 
in this study were found to be foot specific.  
Furthermore, in the current study plantar pressure at the fifth toe was the only plantar pressure parameter that was found to be a significant contributor to 
the explanatory model of ulceration. In the current study an increase in the plantar pressure at the fifth toe has been affiliated to decreased risk of foot 
ulceration with the Odd Ratio of 0.977. This is contrary to the previous study where excessive plantar pressure (>650 kPa) had been found to be significantly 
(OR=5.9, P<0.001) contributing to the explanatory model for foot ulcer 13. This can be related to the fact that an increase in the plantar pressure at the fifth 
toe could decrease the pressure at other plantar sites of the foot by offloading the critical areas of the foot.  
Although from the demographic parameters male sex (OR= 1.44) were also included in the final model contrary to previous studies in South American 
(OR=1.71) 12 population and North American ( OR=2.7) 13 population, the contribution of sex to diagnosis power of the model was not significant (p>0.05).   
Similarly in line with the previous study on North American population 13, previous amputation was included in the final ulceration risk diagnostic model, 
however the contribution was not significant ( P>0.05)   
Overall the discrepancy of the results of the diagnostic model in this study could be the result of the differences in the selected parameters and the participants 
population that were investigated in this study compared to other studies 13 12 11 10 9.   
 
4.4. Strength and Limitations  
This study is unique in a sense that it reports a wide range of foot-specific parameters in a big cohort of Diabetic patients in Africa. In addition, this is the first 
study to report on a wide range of foot-related characteristics along with the clinical and life style factors which are being investigated in patients with DFU 
is compared against those without. This will have implications for clinical practice and have an impact on future research as previous studies did not include 
adequate foot-specific parameter in their model 11 10 9 or when they include the foot specific parameters the ulcerated group contained the participants with 
previous12 or recently healed 13 ulcers or  in addition to those with active foot ulcers which could have affected the results of these studies.  It should be 
mentioned that the results of the current study indicate that the model could justify the lack of DFU with specificity of 99.1 %. Despite the inclusion of number 
of foot-specific parameters in this study, the final model can only justify the presence of foot ulcer with 37.3% sensitivity.  
4.5. Clinical implications and Future directions 
The results of this study can indicate a trend toward considering more foot-specific parameters in identifying the risk of diabetic foot ulceration in patients. 
Additionally, the results can be used to develop specific intervention for diabetic patients with active DFU that is suitable to the distinct characteristics of 
these patients against their non-ulcerated counterparts. These characteristic include the presence of swelling, limited ankle range of motion and distinct small 
fibre neuropathy.  
It worth mentioning that the group of parameters related to the temperature tolerance and sensitivity thresholds to hot and cold stimuli have shown to be 
significantly contributing to explaining foot ulceration.  
Although a vast range of parameters were collected from each participant and the inclusion of further parameters to reflect the micro circulatory 30, and 
mechanical properties of the plantar soft tissue 31  could have resulted in a more comprehensive model of diabetic foot ulceration risk that can achieve higher 
sensitivity in justifying the presence of DFU, however at these were considered to be beyond the scope of this work.  
While few studies have reported severe abnormalities the temperature tolerance and sensitivity thresholds in ulcerated foot 16 32 and have indicated that 
small fibres to be more vulnerable in diabetes, these parameter have not been previously investigated in large cohort studies of this nature. The results of 
the current study justifies the need to assess small fibre neuropathy as a risk factor for foot ulceration in diabetic patients. As outlined in a recent critical 
evaluation of the diabetic foot screening guidelines there is a clear need for more structured data that can provide evidence for the development of screening 
guidelines33. 
 
5. Conclusion: 
Overall, the participants with ulcerated foot show distinct characteristics in a number of clinical parameters including the pronounced impaired sensation and 
foot swelling. 
The combination of parameters collected in this study can explain the common characteristics of patients that can be protective against foot ulceration.  
However only 1 out of three patients with ulcerated foot show common characteristics that can are considered as risk factors for ulceration in this study.  
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 Figure 1: The Sensitivity ( percentage of the group with ulceration occurrence that is correctly identified by the model)  , Specificity ( percentage of the group with No 
ulceration occurrence that is correctly identified by the model), Identification Accuracy ( percentage of the overall group that is correctly identified by the model), along 
with the Diagnosis Strength ( the areas below the Receiver Operation Curve) of the model when the covariates are added in sequential order from left to right. Block 1: The 
model includes covariate A, B & C; Block 2: The model includes covariates: A, B, C, D, E & F; Block 3: The model includes covariates: A, B, C, D, E, F & G; Block 4: The model 
includes covariates: A, B, C, D, E, F, G & H;  Block 5: The model includes covariates: A, B, C, D, E, F, G & H;  Block 6: The model includes covariates: A, B, C, D, E, F, G, H, I, J & 
K; Block 7: The model includes covariates: A, B, C, D, E, F, G, H, I, J, K, L, and M;  Block 7: The model includes covariates: A, B, C, D, E, F, G, H, I, J & K; Block 8: The model 
includes covariates: A, B, C, D, E, F, G, H, I, J, K, L, M and N; Block 9: The model includes covariates: A, B, C, D, E, F, G, H, I, J, K, L, M, N and O.                                                                                                  
Where A: Sex (Male:1, Female:2); B: Duration of Diabetes (in days); C: Blood Glucose level (mmol/L);  D: Amputation (0:without, 1:with); E: Foot deformity (0 without, 1 
with); F: Foot swelling (0:without, 1:with); G: Ankle Mobility ( 0:without, 1:with); H: Sensitivity to monofilament ( 0: Absent, Decreased: 1, Normal: 2); I: Sum of 
Temperature Sensitivity Threshold to cold probe(°c);  J: : Average Temperature Sensitivity Threshold to cold probe(°c);  K: : Average Temperature Tolerance Threshold to 
cold probe(°c);  L: Temperature Tolerance Threshold to hot probe underneath the arch(°c);  M: Sum of Temperature Tolerance Threshold to hot probe (°c); N: Plantar 
pressure at the centre of the Heel ( kPa); O: Plantar pressure at the Fifth Toe ( kPa).   
Block  Parameters  
1  Age, Sex, Weight, Height, Body Mass Index (BMI), Shoe size, Diabetes duration, Smoking 
habit, Alcohol Consumption, and Fasting Blood Sugar Level. 
2 History of amputation, Previous ulceration, presence of Callus, Foot deformity, Swelling, 
and Nail ingrowth. 
3 Ankle Brachial Index, MTP Joint mobility and Ankle Joint Mobility  
4 Vibration Perception Threshold, and sensitivity to Monofilament. 
5 Vibration Perception Thresholds at Wrist, Knee, Ankle and Hallux. 
6 Temperature Sensation and Tolerance Thresholds to Cold probe at Hallux, 1st Toe, 3rd Toe, 
5th Toe, underneath the arch, Heel and the average and the total corresponding values 
for these sites. 
7  Temperature Sensation and Tolerance Thresholds to Hot probe at Hallux, 1st Toe, 3rd Toe, 
5th Toe, underneath the arch, Heel and the average and the total corresponding values 
for these sites. 
8 Plantar Pressure at the lateral midfoot, central midfoot, medial midfoot, lateral hindfoot, 
medical hindfoot, and centre of the hindfoot. 
9 Plantar Pressure at the Lateral Hallux, 2nd Toe, 3rd Toe, 4th Toe, 5th Toe, 1st Met head, 
2nd Met head, 3rd Met head, 4th Met head, and 5th Met head 
 
Table 1: Blocks representing each set of covariates that were added to reach the final explanatory model. 
 
 
 
 
 
 
 
  All (1270) 
No Ulceration 
(1193-93.9%) 
With Ulceration 
(77- 6.1%)         
 
Categorical 
Variable  
No  % No  % No  % 
Odd Ratio  
(CI at 95%) 
P Value 
Multi-
variate 
Analyses  
 P Value for 
differences a  
Effect size 
for 
difference 
Effect size 
classification  
Male sex (1) 696 54.8 643 53.9 53 68.8 
1.488 
(0.784-2.825) 
0.224 0.010 -0.072b small 
Previous Ulceration  
13 1.0% 10 0.8% 3 3.9% 
 
 0.046 
0.072 b small 
Amputation 
4 0.3% 0 0.0% 4 5.2% 
2.932 *109 
(0- ∞) 
0.999 0.000 0.221 b med 
Presence of Callus  
209 16.5% 199 16.7% 10 13.0% 
 
 
0.491 -0.024 b  
Foot deformity  
26 2.0% 19 1.6% 7 9.1% 
3.816  
(0.826-17.632) 
0.086 0.000 0.126 b Small/med 
Mycosis  
34 2.7% 31 2.6% 3 3.9%   0.794 0.019
 b  
Nail Ingrowth 
4 0.3% 2 0.2% 2 2.6% 
 
 
0.008 0.103 b small 
Foot swelling  
76 6.0% 38 3.2% 38 49.4% 
16.456  
(8.199-33.028) 
0.000 0.000 0.464 b large 
No Smoking (1,0) 984 77.5% 930 78.0% 54 70.1%  
 
0.298 0.045 c  Past smoker (0,1) 216 17.0% 199 16.7% 17 22.1%  
Current smoker 
(0,0) 
70 5.5% 64 5.4% 6 7.8%  
No Alcohol cons. 
(Ref) 
721 56.8% 681 57.1% 40 51.9%  
 
0.255 
0.047 c 
 
 Past Alcohol cons.  392 30.9% 362 30.3% 30 39.0%  
Current Alcohol 
cons.  
157 12.4% 150 12.6% 7 9.1%  
Ankle joint Normal 
Mobility 1051 82.8% 1013 84.9% 38 49.4% 
0.438 
(0.231-0.834) 
0.012 0.000 -0.225 b medium 
MTP joint Normal 
Mobility  1049 82.6% 1011 84.7% 38 49.4% 
  0.000 -0.223
 b medium 
Skin viability normal  
125 9.8% 124 10.4% 1 1.3% 
   
 0.002 0.089
 c small Skin viability Dry  1127 88.7% 1054 88.3% 73 94.8%    
Skin Viability Dry 
with fissures  
18 1.4% 15 1.3% 3 3.9%    
Sensitivity to 
Monofilament -
Absent (Ref) 
45 3.5% 28 2.3% 17 22.1%  0.177 
0.000 0.300 c large 
Sensitivity to 
Monofilament-
Impaired  
329 25.9% 292 24.5% 37 48.1% 
0.652 
(0.229-1.861) 
0.424 
Sensitivity to 
Monofilament -
Normal 
896 70.6% 873 73.2% 23 29.9% 
0.337 
(0.096-1.180) 
0.089 
Table 2:  shows the categorical parameters for all participants and for each group of with and with no ulceration. a- P values based on Chi-square test of 
independence (with Yates continuity correction) P <0.5 indicates significant association between ulcerated and non-ulcerated group on the parameter. b- 
Effect size as the Phi coefficient, with small =0.01, Medium = 0.30, Large = 0.50;  c- Effect size as Cramer’s V coefficient (three categories), where small = 
0.07, Medium = 0.21, Large = 0.35; d – Effect size as Cramer’s V coefficient (four categories), where small = 0.06, Medium = 0.17, Large = 0.29 
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Continuous Parameter 
Median IQR N Median IQR N Median IQR N 
Age (year)  52 17.0 1270 52 12.5 1193 53 17.0 77   .177 -.038  
Height (m)  1.60 0.1 1270 1.60 0.1 1193 1.60 0.1 77   .020 -.065 Small 
Weight (Kg)  73.7 20.7 1268 73.6 18.1 1191 74.0 20.8 77   .752 -.009  
Body Mass Index (Kg/m2)  29.4 7.5 1270 29.4 5.5 1193 29.1 7.9 77   .143 -.041  
Shoe size 8 2.0 1268 7 2.0 1191 8 2.0 77   .117 -.044  
Ankle Brachial Index (ABI) 1.1 0.1 1270 1.1 0.1 1193 1.1 0.1 77   .864 -.005  
Vibration Perception Threshold 
Average (V) 
20 
14.3 
1270 20 
15.5 
1193 35 
15.0 
77   .000 -.221 Med 
Duration of Diabetes (days)  
1095 
2747.5 
1270 1095 
4380.0 
1193 2920 
2770.0 
77 
1.017 
(0.973-1.064) 
.453 .000 -.167 Med 
Plantar pressure at Hallux (KPa) 253 155.0 1270 255 171.3 1193 215 152.9 77   .007 -.075 Small 
Plantar pressure at 2nd Toe (KPa) 133 88.0 1270 135 78.8 1193 115 87.5 77   .006 -.078 Small 
Plantar pressure at 3rd Toe (KPa) 88 67.5 1270 90 57.5 1193 68 65.0 77   .000 -.102 Small 
Plantar pressure at 4th Toe (KPa) 58 50.0 1270 60 30.0 1193 48 52.5 77   .002 -.086 Small 
Plantar pressure at 5th Toe (KPa) 
30 
37.5 
1270 30 
25.0 
1193 18 
37.5 
77 
0.977  
(0.862-0.992) 
.003 .000 -.105 Small 
Plantar Pressure 1st MTH (KPa) 160 80.0 1270 158 83.8 1193 193 79.0 77   .004 -.081 Small 
Plantar Pressure at 2nd MTH(KPa) 205 90.0 1270 205 86.3 1193 215 90.0 77   .239 -.033  
Plantar Pressure at 3rd MTH (KPa) 228 90.0 1270 228 86.3 1193 223 90.0 77   .421 -.023  
Plantar Pressure at 4th MTH (KPa) 213 82.5 1270 213 97.5 1193 220 82.5 77   .214 -.035  
Plantar Pressure at 5th MTH (KPa) 180 95.0 1270 180 121.3 1193 198 95.0 77   .042 -.057 Small 
Plantar Pressure at lateral midfoot 
(KPa) 
78 
40.0 
1270 78 
37.5 
1193 78 
40.0 
77   .630 -.014  
Plantar Pressure at centre of midfoot 
(KPa) 
101 
57.5 
1270 101 
65.0 
1193 98 
57.5 
77   .604 -.015  
Plantar Pressure at medial midfoot 
(KPa) 
68 
35.0 
1270 68 
31.3 
1193 68 
35.0 
77   .670 -.012  
Plantar Pressure at lateral hindfoot 
(KPa) 
115 
50.0 
1270 115 
56.8 
1193 110 
50.0 
77   .604 -.015  
Plantar Pressure at medical hind foot 
(KPa) 
170 
52.5 
1270 170 
50.0 
1193 173 
52.5 
77   .915 -.003  
Plantar Pressure at centre of hindfoot 
(KPa) 
122 
62.5 
1270 123 
68.8 
1193 118 
62.5 
77 
1.004 
(0.998-1.010) 
.178 .595 -.015  
TST to Cold probe at Hallux (°C)  
 
29 
3.0 
1254 29 
0.5 
1178 27 
3.0 
76   .000 -.207 Med 
TST to Hot probe at Hallux (°C) 
 
38 
6.0 
1253 38 
1.0 
1177 40 
6.0 
76   .000 -.197 Med 
TTT to Cold probe at Hallux (°C) 21 3.0 1254 21 0.8 1178 19 3.0 76   .000 -.188 Med 
TTT to Hot probe at Hallux (°C) 
 
45 
3.5 
1254 45 
1.3 
1178 47 
3.5 
76   .000 -.219 Med 
TST to Cold probe at 3rd Toe (°C)  
 
29 
2.5 
1254 29 
0.5 
1178 27 
2.5 
76   .000 -.205 Med 
TST to Hot probe at 3rd Toe (°C) 37 5.0 1254 37 0.5 1178 40 5.0 76   .000 -.191 Med 
TTT to Cold probe at 3rd Toe (°C)  21 2.5 1253 21 1.0 1177 19 2.5 76   .000 -.173 Med 
TTT to Hot probe at 3rd Toe (°C) 45 3.5 1254 44 1.5 1178 47 3.5 76   .000 -.198 Med 
TST to Cold probe at 5th Toe (°C)  29 2.0 1253 29 1.0 1177 27 2.0 76   .000 -.196 Med 
TST to Hot probe at 5th Toe (°C) 38 5.0 1254 38 1.0 1178 40 5.5 76   .000 -.192 Med 
TTT to Cold probe at 5th Toe (°C)  21 3.0 1254 21 1.5 1178 19 3.0 76   .000 -.191 Med 
TTT to Hot probe at 5th Toe (°C) 44 3.5 1254 44 1.3 1178 47 3.5 76   .000 -.219 Med 
TST to Cold probe underneath the arch 
(°C)  
28 
3.0 
1254 29 
0.5 
1178 27 
3.0 
76   .000 -.192 Med 
TST to Hot probe underneath the arch 
(°C) 
38 
4.0 
1254 38 
0.5 
1178 40 
4.0 
76   .000 -.189 Med 
TTT to Cold probe underneath the arch 
(°C)  
20 
3.0 
1254 21 
1.3 
1178 19 
3.0 
76   .000 -.174 Med 
TTT to Hot probe underneath the arch 
(°C) 
45 
3.0 
1254 45 
1.0 
1178 47 
3.0 
76 
1.423  
(0.999-2.028) 
.051 .000 -.215 Med 
TST to Cold probe at Heel (°C)  29 3.0 1254 29 0.3 1178 27 3.0 76   .000 -.179 Med 
TST to Hot probe at Heel (°C) 38 3.0 1254 38 1.0 1178 40 3.0 76   .000 -.168 Med 
TTT to Cold probe at Heel (°C)  21 3.0 1254 21 2.0 1178 19 3.0 76   .000 -.159 Med 
TTT to Hot probe at Heel (°C) 45 3.0 1254 45 1.5 1178 48 3.0 76   .000 -.203 Med 
TST to Cold probe Total (°C)  
144 
12.5 
1254 144 
4.3 
1178 133 
12.0 
76 
0.998  
(0.927-1.074) 
.955 .000 -.236 Med 
TST to Hot probe Total (°C) 185 23.5 1254 185 16.5 1178 198 24.0 76   .027 -.062 Small 
TTT to Cold probe Total (°C)  104 13.5 1254 104 7.5 1178 93 13.5 76   .000 -.174 Med 
TTT to Hot probe Total (°C) 221 
17.0 
1254 220 
19.5 
1178 233 
16.5 
76 
0.975 
(0.948-1.003) 
.080 .170 -.039  
TST to Cold probe Average (°C)  
29 
2.5 
1248 29 
0.4 
1173 27 
2.4 
75 
0.630 
(0.445-0.891) 
.009 .000 -.218 Med 
TST to Hot probe Average (°C) 37 4.7 1254 37 1.0 1178 40 4.9 76   .000 -.154 Med 
TTT to Cold probe Average (°C)  
21 
2.7 
1251 21 
0.9 
1175 19 
2.7 
76 
1.399 
(1.096-1.786) 
.007 .000 -.167 Med 
TTT to Hot probe Average (°C) 44 3.3 1251 44 0.8 1175 47 3.3 76   .000 -.195 Med 
Vibration Perception Threshold Wrist 
(V) 
11 
4.0 
1270 11 
3.5 
1193 14 
3.5 
77   .000 -.178 Med 
Vibration Perception Threshold Knee 
(V) 
22 
12.0 
1267 22 
10.0 
1190 30 
11.5 
77   .000 -.193 Med 
Vibration Perception Threshold Ankle 
(V) 
21 
13.5 
1270 20 
13.3 
1193 34 
13.0 
77   .000 -.222 Med 
Vibration Perception Threshold Hallux 
(V) 
21 
15.0 
1270 21 
16.5 
1193 36 
15.0 
77   .000 -.231 Med 
Blood Glucose Level (mmol/L) 
12 
7.9 
1269 12 
7.0 
1192 10 
7.9 
77 
0.938 
(0.885-0.995) 
.032 .002 -.085 Small 
 
Table 3: shows the continuous parameters for all participants and for the groups with and with no ulceration. a- Mann-Whitney; r = z / (N1 + N2 
)0.5 where 0.1 small effect, 0.3 medium effect, 0.5 large effect; Note that the selection of parameters in the logistic regression model was based 
on the univariate analyses in which parameters with P<0.2 were selected. The P values for these selected parameters are underlined in the 
table.  
 
 
